National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average - Should You Sell?

Key Points

• National Research shares crossed above their 200-day moving average, reaching $20.49 and last trading at $20.43, compared with a 200-day average of $19.91.
• Analyst sentiment is mixed, with one Buy, one Hold and one Sell rating; the overall consensus is Hold with an average price target of $26.00.
• The company beat quarterly expectations, reporting $0.31 in earnings per share versus a consensus estimate of a $0.15 loss, while revenue of $35.39 million also exceeded forecasts.

National Research Corporation (NASDAQ:NRC - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $19.91 and traded as high as $20.49. National Research shares last traded at $20.43, with a volume of 78,775 shares traded.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on NRC shares. Weiss Ratings lowered shares of National Research from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, October 9th. Zacks Research raised National Research to a "hold" rating in a research note on Monday, October 5th. Citizens Jmp raised their price objective on National Research from $23.00 to $26.00 and gave the company a "market outperform" rating in a research note on Wednesday, July 29th. Finally, Wall Street Zen downgraded National Research from a "buy" rating to a "hold" rating in a report on Saturday, August 15th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, National Research has a consensus rating of "Hold" and an average price target of $26.00.

National Research Price Performance

The stock has a market capitalization of $464.70 million, a P/E ratio of 81.72 and a beta of 0.25. The business's 50 day simple moving average is $21.08 and its two-hundred day simple moving average is $19.91. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 13.13.

National Research (NASDAQ:NRC - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of ($0.15) by $0.46. National Research had a net margin of 4.18% and a return on equity of 164.26%. The company had revenue of $35.39 million during the quarter, compared to the consensus estimate of $34.90 million. As a group, sell-side analysts forecast that National Research Corporation will post 0.98 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of NRC. Empirical Finance LLC bought a new stake in National Research during the second quarter worth $431,000. Empowered Funds LLC purchased a new stake in National Research in the 1st quarter valued at $226,000. Bank of America Corp DE lifted its stake in National Research by 3.0% during the 1st quarter. Bank of America Corp DE now owns 112,468 shares of the company's stock valued at $1,910,000 after acquiring an additional 3,323 shares in the last quarter. Quantinno Capital Management LP lifted its stake in National Research by 61.3% during the 1st quarter. Quantinno Capital Management LP now owns 62,329 shares of the company's stock valued at $1,058,000 after acquiring an additional 23,682 shares in the last quarter. Finally, Heartland Advisors Inc. lifted its stake in National Research by 374.3% during the 1st quarter. Heartland Advisors Inc. now owns 237,147 shares of the company's stock valued at $4,027,000 after acquiring an additional 187,147 shares in the last quarter. Institutional investors own 47.26% of the company's stock.

National Research Company Profile

National Research Corporation, formerly traded on the Nasdaq under the symbol NRC and known as NRC Health, provides market research, analytics and performance-improvement services to healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers understand the experiences and expectations of patients, employees, physicians and communities.

The company's offerings have included patient-experience measurement, employee and physician engagement surveys, reputation and brand research, community health assessments, data analytics and advisory services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.